Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects

American Journal of Respiratory and Critical Care Medicine

Volumn 191, Issue 4, 2015, Pages 464-473

  Neff, C Preston ^a   Chain, Jennifer L ^a   MaWhinney, Samantha ^b   Martin, Allison K ^a   Linderman, Derek J ^a   Flores, Sonia C ^a   Campbell, Thomas B ^a   Palmer, Brent E ^a   Fontenot, Andrew P ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Cytokines; HIV; Lung; Programmed cell death 1 receptor; T cells

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; KI 67 ANTIGEN; PROGRAMMED DEATH 1 RECEPTOR; BIOLOGICAL MARKER; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FUNCTIONAL STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LUNG ALVEOLITIS; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC ALVEOLITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; VIRUS LOAD; BRONCHOALVEOLAR LAVAGE FLUID; CASE CONTROL STUDY; COMPLICATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LUNG; LUNG DISEASE; LYMPHOCYTE ACTIVATION; METABOLISM; VIROLOGY;

BIOMARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; LUNG; LUNG DISEASES; LYMPHOCYTE ACTIVATION; PROGRAMMED CELL DEATH 1 RECEPTOR;

EID: 84922949106     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201408-1521OC     Document Type: Article

References (38)

1. Gingo MR, Morris A. Pathogenesis of HIV and the lung. Curr HIV/AIDS Rep 2013;10:42-50.
2. Crothers K, Huang L, Goulet JL, Goetz MB, Brown ST, Rodriguez- Barradas MC, Oursler KK, Rimland D, Gibert CL, Butt AA, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011;183: 388-395.
3. Benito N, Moreno A, Filella X, Miró JM, González J, Pumarola T, Valls ME, Luna M, García F, Rañó A, et al. Inflammatory responses in blood samples of human immunodeficiency virus-infected patients with pulmonary infections. Clin Diagn Lab Immunol 2004;11: 608-614.
4. Twigg HL III, Spain BA, Soliman DM, Knox K, Sidner RA, Schnizlein-Bick C, Wilkes DS, Iwamoto GK. Production of interferon-gamma by lung lymphocytes in HIV-infected individuals. Am J Physiol 1999;276: L256-L262.
5. Twigg HL, Soliman DM, Day RB, Knox KS, Anderson RJ, Wilkes DS, Schnizlein-Bick CT. Lymphocytic alveolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection. Am J Respir Crit Care Med 1999;159:1439-1444.
6. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004;4:336-347.
7. Crawford A, Wherry EJ. The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses. Curr Opin Immunol 2009;21:179-186.
8. Watts TH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005;23:23-68.
9. Kaufmann DE, Walker BD. Programmed death-1 as a factor in immune exhaustion and activation in HIV infection. Curr Opin HIV AIDS 2008;3: 362-367.
10. Kaufmann DE, Kavanagh DG, Pereyra F, Zaunders JJ, Mackey EW, Miura T, Palmer S, Brockman M, Rathod A, Piechocka-Trocha A, et al. Upregulation of CTLA-4 by HIV-specific CD41 T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 2007;8:1246-1254.
11. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006;443:350-354.
12. D'Souza M, Fontenot AP, Mack DG, Lozupone C, Dillon S, Meditz A, Wilson CC, Connick E, Palmer BE. Programmed death 1 expression on HIV-specific CD41 T cells is driven by viral replication and associated with T cell dysfunction. J Immunol 2007; 179:1979-1987.
13. Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, Boulassel MR, Delwart E, Sepulveda H, Balderas RS, et al. Upregulation of PD-1 expression on HIV-specific CD81 T cells leads to reversible immune dysfunction. Nat Med 2006;12:1198-1202.
14. Finnefrock AC, Tang A, Li F, Freed DC, Feng M, Cox KS, Sykes KJ, Guare JP, Miller MD, Olsen DB, et al. PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination. J Immunol 2009;182:980-987.
15. Chain JL, Martin AK, Mack DG, Maier LA, Palmer BE, Fontenot AP. Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation. J Immunol 2013;191:1648-1656.
16. Seung E, Dudek TE, Allen TM, Freeman GJ, Luster AD, Tager AM. PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads. PLoS ONE 2013;8:e77780.
17. Kassu A, Marcus RA, D'Souza MB, Kelly-McKnight EA, Golden-Mason L, Akkina R, Fontenot AP, Wilson CC, Palmer BE. Regulation of virus-specific CD41 T cell function by multiple costimulatory receptors during chronic HIV infection. J Immunol 2010;185: 3007-3018.
18. Mack DG, Lanham AM, Falta MT, Palmer BE, Maier LA, Fontenot AP. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects. Am J Respir Crit Care Med 2010;181: 1241-1249.
19. Palmer BE, Mack DG, Martin AK, Gillespie M, Mroz MM, Maier LA, Fontenot AP. Up-regulation of programmed death-1 expression on beryllium-specific CD41 T cells in chronic beryllium disease. J Immunol 2008;180:2704-2712.
20. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-974.
21. Palmer BE, Boritz E, Blyveis N, Wilson CC. Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD41 T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication. J Virol 2002;76:5925-5936.
22. Younes SA, Yassine-Diab B, Dumont AR, Boulassel MR, Grossman Z, Routy JP, Sekaly RP. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD41 T cells endowed with proliferative capacity. J Exp Med 2003;198:1909-1922.
23. McNeil AC, Shupert WL, Iyasere CA, Hallahan CW, Mican JA, Davey RT Jr, Connors M. High-level HIV-1 viremia suppresses viral antigenspecific CD4(1) T cell proliferation. Proc Natl Acad Sci USA 2001;98: 13878-13883.
24. El-Far M, Halwani R, Said E, Trautmann L, Doroudchi M, Janbazian L, Fonseca S, van Grevenynghe J, Yassine-Diab B, Sé kaly RP, et al. T-cell exhaustion in HIV infection. Curr HIV/AIDS Rep 2008;5: 13-19.
25. Guillon JM, Autran B, Denis M, Fouret P, Plata F, Mayaud CM, Akoun GM. Human immunodeficiency virus-related lymphocytic alveolitis. Chest 1988;94:1264-1270.
26. Autran B, Mayaud CM, Raphael M, Plata F, Denis M, Bourguin A, Guillon JM, Debre P, Akoun G. Evidence for a cytotoxic Tlymphocyte alveolitis in human immunodeficiency virus-infected patients. AIDS 1988;2:179-183.
27. Agostini C, Facco M, Siviero M, Carollo D, Galvan S, Cattelan AM, Zambello R, Trentin L, Semenzato G. CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD81/CXCR31 T cells in the lungs of patients with HIV infection and T-cell alveolitis. Am J Respir Crit Care Med 2000;162:1466-1473.
28. Denis M, Ghadirian E. Alveolar macrophages from subjects infected with HIV-1 express macrophage inflammatory protein-1 alpha (MIP-1 alpha): contribution to the CD81 alveolitis. Clin Exp Immunol 1994; 96:187-192.
29. Twigg HL III, Knox KS. Impact of antiretroviral therapy on lung immunology and inflammation. Clin Chest Med 2013;34:155-164.
30. Semenzato G, Agostini C, Chieco-Bianchi L, De Rossi A. HIV load in highly purified CD81 T cells retrieved from pulmonary and blood compartments. J Leukoc Biol 1998;64:298-301.
31. Costiniuk CT, Jenabian MA. The lungs as anatomical reservoirs of HIV infection. Rev Med Virol 2014;24:35-54.
32. Brenchley JM, Knox KS, Asher AI, Price DA, Kohli LM, Gostick E, Hill BJ, Hage CA, Brahmi Z, Khoruts A, et al. High frequencies of polyfunctional HIV-specific T cells are associated with preservation of mucosal CD4 T cells in bronchoalveolar lavage. Mucosal Immunol 2008;1:49-58.
33. Jambo KC, Banda DH, Kankwatira AM, Sukumar N, Allain TJ, Heyderman RS, Russell DG, Mwandumba HC. Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function. Mucosal Immunol 2014;7: 1116-1126.
34. Tan J, Sattentau QJ. The HIV-1-containing macrophage compartment: a perfect cellular niche? Trends Microbiol 2013;21: 405-412.
35. Horiike M, Iwami S, Kodama M, Sato A, Watanabe Y, Yasui M, Ishida Y, Kobayashi T, Miura T, Igarashi T. Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy. Virology 2012;423:107-118.
36. Migueles SA, Weeks KA, Nou E, Berkley AM, Rood JE, Osborne CM, Hallahan CW, Cogliano-Shutta NA, Metcalf JA, McLaughlin M, et al. Defective human immunodeficiency virus-specific CD81 T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol 2009;83:11876-11889.
37. Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V, Subramaniam S, Blattman JN, Barber DL, Ahmed R. Molecular signature of CD81 T cell exhaustion during chronic viral infection. Immunity 2007;27:670-684.
38. Nakamoto N, Kaplan DE, Coleclough J, Li Y, Valiga ME, Kaminski M, Shaked A, Olthoff K, Gostick E, Price DA, et al. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 2008;134: 1927-1937, e1-e2.